Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet Inks Contract With NY Bioscience Cluster

NEW YORK (GenomeWeb) – Arrayjet said today that it has secured an approximately $250,000 contract with the New York Bioscience Cluster for microarray instrumentation, printing, and expertise.

The Bronx-based NYBC provides gene expression research services for diseases and disorders related to immunology, cancer, diabetes, and liver function, and will use Arrayjet's Marathon Argus high-throughput bioprinter for much of this work, Edinburgh, Scotland-based Arrayjet said.

In addition, the NYBC will use Arrayjet Advance, an outsourced customized microarray printing service launched by Arrayjet in 2011. This allows NYBC to access application support through Arrayjet, which will perform proof-of-principle studies for protein and DNA printing prior to purchase, the company said.